Stay updated on Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial

Sign up to get notified when there's something new on the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:13:22.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the study's evaluation of the safety and immunogenicity of sequential administration of Prevnar 13™ and Pneumovax™ 23 in healthy participants 50 years of age and older, focusing on specific hypotheses related to pneumococcal serotypes.
    Difference
    0.1%
    Check dated 2024-06-06T14:31:10.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for study participants, specifying conditions for inclusion and exclusion. Previously, no information was provided regarding participation criteria.
    Difference
    27%
    Check dated 2024-05-22T21:14:38.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:17:51.000Z thumbnail image

Stay in the know with updates to Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page.